CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
+56.41%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.76B
AUM Growth
+$1.76B
Cap. Flow
-$130M
Cap. Flow %
-7.41%
Top 10 Hldgs %
61.02%
Holding
81
New
8
Increased
13
Reduced
7
Closed
19

Top Buys

1
MLTX icon
MoonLake Immunotherapeutics
MLTX
$63.7M
2
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
$30.9M
3
CBAY
Cymabay Therapeutics
CBAY
$27.7M
4
EYPT icon
EyePoint Pharmaceuticals
EYPT
$25.9M
5
PCVX icon
Vaxcyte
PCVX
$19.5M

Top Sells

1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$178M
2
PLRX icon
Pliant Therapeutics
PLRX
$38.4M
3
ETNB icon
89bio
ETNB
$27.5M
4
RAIN
Rain Oncology Inc. Common Stock
RAIN
$26M
5
GLUE icon
Monte Rosa Therapeutics
GLUE
$22.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KRTX
26
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$17.3M 0.97%
80,000
– –
LBPH
27
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$17.3M 0.97%
2,353,141
– –
RCKT icon
28
Rocket Pharmaceuticals
RCKT
$358M
$17.3M 0.97%
868,550
– –
AXNX
29
DELISTED
Axonics, Inc. Common Stock
AXNX
$16.3M 0.91%
322,240
– –
SRPT icon
30
Sarepta Therapeutics
SRPT
$1.98B
$14.9M 0.83%
130,000
+20,000
+18% +$2.29M
PHVS icon
31
Pharvaris
PHVS
$1.41B
$14.7M 0.83%
973,614
+157,154
+19% +$2.38M
IDYA icon
32
IDEAYA Biosciences
IDYA
$2.26B
$14.1M 0.79%
600,000
+250,000
+71% +$5.88M
COGT icon
33
Cogent Biosciences
COGT
$1.83B
$11.8M 0.66%
1,000,000
+300,000
+43% +$3.55M
STOK icon
34
Stoke Therapeutics
STOK
$1.08B
$11.6M 0.65%
1,087,807
– –
PRAX icon
35
Praxis Precision Medicines
PRAX
$980M
$10.9M 0.61%
+9,500,000
New +$10.9M
IMVT icon
36
Immunovant
IMVT
$2.91B
$10.4M 0.58%
+550,000
New +$10.4M
IRON icon
37
Disc Medicine
IRON
$2.14B
$9.99M 0.56%
+225,000
New +$9.99M
RYTM icon
38
Rhythm Pharmaceuticals
RYTM
$6.75B
$9.89M 0.55%
+600,000
New +$9.89M
LIAN
39
DELISTED
LianBio American Depositary Shares
LIAN
$9.69M 0.54%
4,250,000
– –
MORF
40
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$8.6M 0.48%
150,000
-175,000
-54% -$10M
ATXS icon
41
Astria Therapeutics
ATXS
$394M
$8.33M 0.47%
1,000,000
– –
ARQT icon
42
Arcutis Biotherapeutics
ARQT
$1.91B
$7.62M 0.43%
+800,000
New +$7.62M
GHRS icon
43
GH Research
GHRS
$870M
$7.04M 0.39%
593,043
– –
VERV
44
DELISTED
Verve Therapeutics
VERV
$6.56M 0.37%
350,000
– –
RAPT icon
45
RAPT Therapeutics
RAPT
$187M
$6.08M 0.34%
325,000
-325,000
-50% -$6.08M
VIGL
46
DELISTED
Vigil Neuroscience
VIGL
$5.8M 0.32%
616,786
– –
AVIR icon
47
Atea Pharmaceuticals
AVIR
$275M
$5.79M 0.32%
1,547,181
– –
AKRO icon
48
Akero Therapeutics
AKRO
$3.65B
$5.37M 0.3%
+115,000
New +$5.37M
ALXO icon
49
ALX Oncology
ALXO
$54.6M
$4.6M 0.26%
612,079
– –
BCAB icon
50
BioAtla
BCAB
$28.7M
$3.54M 0.2%
1,181,115
– –
1
2
3 4